90 related articles for article (PubMed ID: 10208931)
1. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
Chang JC; Seidel C; Ofenloch B; Jue DL; Fields HA; Khudyakov YE
Virology; 1999 Apr; 257(1):177-90. PubMed ID: 10208931
[TBL] [Abstract][Full Text] [Related]
2. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
3. Antigenic epitopes of the hepatitis A virus polyprotein.
Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
[TBL] [Abstract][Full Text] [Related]
5. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
[TBL] [Abstract][Full Text] [Related]
6. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
[TBL] [Abstract][Full Text] [Related]
8. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.
Khudyakov Yu E; Khudyakova NS; Jue DL; Lambert SB; Fang S; Fields HA
Virology; 1995 Jan; 206(1):666-72. PubMed ID: 7530398
[TBL] [Abstract][Full Text] [Related]
9. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
[TBL] [Abstract][Full Text] [Related]
10. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
[TBL] [Abstract][Full Text] [Related]
11. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
Cerino A; Mondelli MU
J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
15. Selection and application of serotypical synthetic peptides derived from hepatitis C virus NS5A region.
Dou XG; Zhang L; Li ZW; Feng GH; Chang J; Fildes H; Khudyakov Y
Chin Med J (Engl); 2007 Jul; 120(13):1159-65. PubMed ID: 17637245
[TBL] [Abstract][Full Text] [Related]
16. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
[TBL] [Abstract][Full Text] [Related]
17. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
19. Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1.
Franco S; Tural C; Clotet B; Martínez MA
Virus Res; 2007 Feb; 123(2):161-9. PubMed ID: 17023084
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and antigenic activity of peptides from the C-terminal part of the NS4-protein of the hepatitis A virus].
Semiletov IuA; Firsova TV; Kuzin SN; Khudiakov IuE; Shibnev VA
Bioorg Khim; 1993 Nov; 19(11):1128-31. PubMed ID: 8285926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
